Showing 1561-1570 of 2105 results for "".
Epilepsy Essentials: Neuromodulation for Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-neuromodulation-for-drug-resistant-epilepsy/31805/Neuromodulation devices provide options for individuals with drug-resistant epilepsy not suited, or not responsive, to resective treatment.The Importance of Sleep
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-importance-of-sleep/30106/Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.Movement Disorders Moment: Rapid Eye Movement Sleep Behavior Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-rapid-eye-movement-sleep-behavior-disorder/30117/This sleep disorder is a strong predictor for the development of synucleinopathies, including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies.Action Tremor and Gait Imbalance With Eventual Cognitive Decline
https://practicalneurology.com/diseases-diagnoses/movement-disorders/action-tremor-and-gait-imbalance-with-eventual-cognitive-decline-video/30249/Exploring Expanded Labeling for DBS for Parkinson's
https://practicalneurology.com/diseases-diagnoses/movement-disorders/exploring-expanded-labeling-for-dbs-for-parkinsons/30694/Expanded labeling is based on data showing an improvement in quality of life and longer-term data.Pathway to Success? MS Drug Takes Nrf-2 Pathway for Treatment
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pathway-to-success-ms-drug-takes-nrf-2-pathway-for-treatment/30774/BG-12 is an oral therapy under regulatory review in the US and Europe for the treatment of MS.Letter to the Editor: A Clarification on Dalfampridine (Ampyra) Dosing and Other Data
https://practicalneurology.com/columns/practice-management/letter-to-the-editor-a-clarification-on-dalfampridine-ampyra-dosing-and-other-data/30855/A Breathtaking Evolution of Therapeutic Approaches
https://practicalneurology.com/diseases-diagnoses/movement-disorders/a-breathtaking-evolution-of-therapeutic-approaches/30237/Can the Private Practice Survive in the Age of Consolidation?
https://practicalneurology.com/columns/practice-management/can-the-private-practice-survive-in-the-age-of-consolidation/30326/In the rapidly changing health care economy, increasing regulation and the expanding influence of third-party payers are diminishing the physician's role.In-Focus: Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/in-focus-movement-disorders/30381/